Aurélie Chauffour

7PUBLICATIONS
22CO-AUTHORS
Medical bacteriologyMolecular targetsMedical devicesMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 07, 2026
Alpibectir-Ethionamide combination (AlpE) for the treatment of tuberculosis.

Zainab Edoo, Camille Grosse, Thomas Maitre

|Oct 22, 2025
The role of cytochrome bc1 inhibitors in future tuberculosis treatment regimens.

Clara Aguilar-Pérez, Anne J Lenaerts, Cristina Villellas

|Sep 01, 2020
Telacebec (Q203)-containing intermittent oral regimens sterilized mice infected with Mycobacterium ulcerans after only 16 doses.

Aurélie Chauffour, Jérôme Robert, Nicolas Veziris

|May 21, 2020
Fully weekly antituberculosis regimen: a proof-of-concept study.

Fatma Kort, Laure Fournier Le Ray, Aurélie Chauffour

|Dec 19, 2018
Targeting the Mycobacterium ulcerans cytochrome bc1:aa3 for the treatment of Buruli ulcer.

Nicole Scherr, Raphael Bieri, Sangeeta S Thomas

Pageof 2